---
title: "Tharimmune (THAR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/THAR.US.md"
symbol: "THAR.US"
name: "Tharimmune"
industry: "Biotechnology"
---

# Tharimmune (THAR.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillst...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -18.16 | 499/606 | - | - | - |
| PB | 30.44 | 421/606 | 46.28 | 17.74 | 2.08 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-01-22T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.74 |

## References

- [Company Overview](https://longbridge.com/en/quote/THAR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/THAR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/THAR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.